In Vivo is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

Edwards Lifesciences Corp.

https://www.edwards.com/gb

Latest From Edwards Lifesciences Corp.

FDA AdCom Will Scrutinize Placebo Benefit Of Abbott’s TriClip G4 TTVR

An FDA advisory panel will discuss Abbott’s PMA for the TriClip G4 transcatheter tricuspid valve repair device on 13 February. The group’s discussion will likely focus on the lack of a clear mortality or hospitalization benefit in the TRILUMINATE pivotal trial.

Advisory Committees Cardiology

Cardio Catch-Up: FDA Approves Edwards Evoque Transcatheter Tricuspid Valve Sooner Than Expected

Edwards' Evoque is the first transcatheter therapy to receive FDA approval for the treatment of tricuspid regurgitation. The FDA-approved labeling says it can improve patients' "health status" but the company may be able to soon upgrade that indication to include a mortality benefit claim, which could give Evoque an important advantage over tricuspid valve repair devices.

Commercial Clinical Trials

News We’re Watching: Intuitive Plans da Vinci 5 Launch; Roche’s CGM Plan; ReWalk Rebrands, And More

Medtech Insight's News We're Watching highlights medtech industry developments we are following: Intuitive announced an FDA filing for its da Vinci 5 surgical robot; Roche hits at CGM plans; Abbott launches a new smaller rechargeable deep brain stimulator; CroiValve starts transcatheter tricuspid valve trial; ReWalk rebrands as Lifeward; and more news you may have missed.

News We're Watching Clinical Trials

JPM 2024 Roundup: Abbott And Medtronic Push Diabetes Tech, Edwards Updates Tricuspid Progress, Shockwave Bets On R&D

Medtech Insight covered the major announcements from medtech companies during the J.P. Morgan Healthcare Conference in early January. Here are a few more highlights from companies that may not have made the headlines but will, no doubt, make noise in 2024.

Innovation Business Strategies
See All

Company Information

  • Industry
  • Medical Devices
    • Implantable Devices
    • Infusion Therapy Equipment and Supplies
    • Monitoring Equipment & Devices
    • Surgical Equipment & Devices
  • Other Names / Subsidiaries
    • CardiAQ Valve Technologies, Inc.
    • CAS Medical Systems, Inc.
    • Embrella Cardiovascular, Inc.
    • Harpoon Medical, Inc.
    • Percutaneous Valve Technologies, Inc.
    • Valtech Cardio, Ltd.
UsernamePublicRestriction

Register